← Eichor
Study identifier: NCT00187512 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era

Condition: HIV Infections  ·  Sponsor: University of California, San Francisco

PhaseN/A
Planned participants2500
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

SCOPE is an observational, prospective study of HIV-1 infected volunteers designed to provide a specimen bank of samples with carefully characterized clinical data. SCOPE specimens will be used to examine multiple questions involving virologic, immunologic, and host factors involved in HIV-1 infection, progression, non-progression, response to treatment, control of HIV-1 virus, and evolution of drug resistance.

This description comes directly from the study's public registry record.

Talk to the study team

Rebecca Hoh, M.S., R.D.  ·  415-476-4082  ·  Rebecca.Hoh@ucsf.edu

Montha Pao  ·  415-476-4082  ·  Montha.Pao@ucsf.edu

Always discuss trial participation with your own doctor first.

Locations (1)

San Francisco General HospitalSan Francisco, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT00187512